Kondracki Celej advised Pawel Sieczkiewicz, the founder of Telemedi - Digital Health Platform & Telehealth Provider, and the company’s investors, on the sale of a majority stake of shares in Telemedi to Mavie Next, an Austrian based healthcare provider 🤝 🎯
Our legal team, led by Rafał Celej and supported by Arek Klejnowski, Monika Twerdochlib and Gabriela Lewicka, prepared the comprehensive transaction documentation, and provided full support to the sellers at every stage of the negotiations, ensuring a successful closing 🎯
Kondracki Celej previously advised Telemedi on the series A investment round in 2021.
🤝 We extend our sincere appreciation to the Telemedi team – Pawel Sieczkiewicz, Dmitry Smirnov, Monika Lubecka and Jakub Jankowski for their trust and collaboration throughout the process, as well as to the investors and Telemedi board members: Marcin Szczecinski at Adamed Pharma, Kate Cottrell and Peter Bialo at DocPlanner, Aleksander Dobrzyniecki and Marcin P. Kowalik at Black Pearls VC, Magdalena Gałan and Marton M. at Flashpoint Venture Capital, Krzysztof Mazur and Krzysztof Tokarski at PKO Bank Polski(VC), and Bori FARKAS-FOZY and Elena Tóth at UNIQA Ventures- congratulation on this great exit!
💪🏼 Additionally, our gratitude goes to Mateusz Kurysz and Erich Kruschitz at Mavie Next and our colleagues from Rymarz Zdort Maruta– Jacek Zawadzki, Małgorzata Deruś and Patrycja Gliwka, as well as Jacek Balicki at BCGL for a smooth cooperation during the entire process.
